Kovitz Investment Group Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.03M | Buy |
66,758
+24,856
| +59% | +$2.87M | 0.19% | 108 |
|
|
2025
Q4 | $4.41M | Sell |
41,902
-325,351
| -89% | -$30.5M | 0.1% | 151 |
|
|
2025
Q3 | $30.9M | Sell |
367,253
-936,627
| -72% | -$77.1M | 0.12% | 161 |
|
|
2025
Q2 | $103M | Sell |
1,303,880
-204,026
| -14% | -$16.2M | 0.44% | 61 |
|
|
2025
Q1 | $135M | Buy |
1,507,906
+167,772
| +13% | +$15.7M | 0.68% | 36 |
|
|
2024
Q4 | $133M | Buy |
1,340,134
+1,119,080
| +506% | +$115M | 0.65% | 39 |
|
|
2024
Q3 | $21M | Buy |
221,054
+99,236
| +81% | +$11.8M | 0.15% | 130 |
|
|
2024
Q2 | $15.1M | Sell |
121,818
-380
| -0.3% | -$48.9K | 0.13% | 121 |
|
|
2024
Q1 | $16.1M | Buy |
122,198
+36,127
| +42% | +$4.45M | 0.2% | 72 |
|
|
2023
Q4 | $9.38M | Sell |
86,071
-107
| -0.1% | -$11.1K | 0.16% | 73 |
|
|
2023
Q3 | $8.87M | Sell |
86,178
-3,748
| -4% | -$404K | 0.16% | 78 |
|
|
2023
Q2 | $10.4M | Sell |
89,926
-5,663
| -6% | -$643K | 0.15% | 67 |
|
|
2023
Q1 | $10.2M | Sell |
95,589
-3,144
| -3% | -$339K | 0.18% | 71 |
|
|
2022
Q4 | $11M | Sell |
98,733
-877
| -0.9% | -$89.6K | 0.22% | 68 |
|
|
2022
Q3 | $8.58M | Buy |
99,610
+753
| +0.8% | +$67.2K | 0.2% | 78 |
|
|
2022
Q2 | $9.01M | Sell |
98,857
-5,925
| -6% | -$525K | 0.2% | 80 |
|
|
2022
Q1 | $8.6M | Buy |
104,782
+11,622
| +12% | +$916K | 0.16% | 91 |
|
|
2021
Q4 | $7.62M | Sell |
93,160
-69,336
| -43% | -$5.52M | 0.18% | 84 |
|
|
2021
Q3 | $12.2M | Sell |
162,496
-796
| -0.5% | -$60.5K | 0.24% | 57 |
|
|
2021
Q2 | $12.7M | Buy |
163,292
+39,507
| +32% | +$2.94M | 0.25% | 55 |
|
|
2021
Q1 | $9.11M | Buy |
123,785
+26,154
| +27% | +$1.93M | 0.21% | 78 |
|
|
2020
Q4 | $7.62M | Sell |
97,631
-2,563
| -3% | -$196K | 0.19% | 82 |
|
|
2020
Q3 | $7.93M | Buy |
100,194
+2,482
| +3% | +$194K | 0.22% | 73 |
|
|
2020
Q2 | $7.21M | Buy |
97,712
+24,856
| +34% | +$1.87M | 0.22% | 71 |
|
|
2020
Q1 | $5.35M | Buy |
72,856
+3,288
| +5% | +$258K | 0.19% | 87 |
|
|
2019
Q4 | $6.04M | Sell |
69,568
-343
| -0.5% | -$28.2K | 0.18% | 90 |
|
|
2019
Q3 | $989K | Buy |
69,911
+2,525
| +4% | +$202K | 0.03% | 266 |
|
|
2019
Q2 | $5.39M | Buy |
67,386
+10,313
| +18% | +$790K | 0.17% | 94 |
|
|
2019
Q1 | $4.53M | Buy |
57,073
+1,019
| +2% | +$76.2K | 0.14% | 107 |
|
|
2018
Q4 | $4.09M | Buy |
56,054
+51,225
| +1,061% | +$3.62M | 0.16% | 98 |
|
|
2018
Q3 | $327K | Buy |
4,829
+53
| +1% | +$3.38K | 0.01% | 130 |
|
|
2018
Q2 | $277K | Sell |
4,776
-676
| -12% | -$38.1K | 0.01% | 134 |
|
|
2018
Q1 | $283K | Sell |
5,452
-515
| -9% | -$27.8K | 0.01% | 129 |
|
|
2017
Q4 | $320 | Buy |
5,967
+15
| +0.3% | +$832 | 0.01% | 136 |
|
|
2017
Q3 | $364K | Sell |
5,952
-104
| -2% | -$6.3K | 0.02% | 128 |
|
|
2017
Q2 | $370K | Sell |
6,056
-413
| -6% | -$25.1K | 0.02% | 129 |
|
|
2017
Q1 | $392K | Buy |
6,469
+110
| +2% | +$6.67K | 0.02% | 108 |
|
|
2016
Q4 | $357K | Buy |
6,359
+314
| +5% | +$18.4K | 0.02% | 99 |
|
|
2016
Q3 | $360K | Hold |
6,045
| – | – | 0.02% | 109 |
|
|
2016
Q2 | $332K | Buy |
6,045
+71
| +1% | +$3.78K | 0.02% | 111 |
|
|
2016
Q1 | $302K | Buy |
+5,974
| New | +$293K | 0.02% | 117 |
|
Other funds holding MRK
VCM
VPM
Kovitz Investment Group Partners's MRK Position: Q1 2026 in Review
Kovitz Investment Group Partners increased its Merck (MRK) stake by 59% in Q1 2026, buying an estimated $2.87M and bringing the position to 66,758 shares worth $8.03M. The position accounts for 0.19% of the portfolio, ranked #108.
Kovitz Investment Group Partners first reported a position in MRK in Q1 2016 and has held it in 41 quarters since. The position peaked at $135M in Q1 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Kovitz Investment Group Partners held 66,758 shares of Merck worth $8.03M as of Q1 2026.
- Kovitz Investment Group Partners bought 24,856 Merck shares in Q1 2026, an estimated $2.87M.
- Merck made up 0.19% of Kovitz Investment Group Partners's portfolio in Q1 2026, its #108 holding.
- Kovitz Investment Group Partners first reported a position in Merck in Q1 2016 and has held it in 41 quarters since.
- Kovitz Investment Group Partners's Merck position peaked at $135M in Q1 2025.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Kovitz Investment Group Partners's 13F filing for Q1 2026, filed 13 May 2026.